AG
SIOX

Aperio Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Aperio Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-366
Closed -$2K – 2872
2019
Q2 		$2K Buy
+366
New +$2.79K ﹤0.01% 2951

Other funds holding SIOX

SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Aperio Group's SIOX Position: Q3 2019 in Review

Aperio Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2019, closing a stake of 366 shares — an estimated $2K sold.

Aperio Group first reported a position in SIOX in Q2 2019 and held it in 1 quarter. The position peaked at $2K in Q2 2019. 48 funds tracked by Wall St. Rank hold SIOX as of Q3 2019.

  • Aperio Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 366 Sio Gene Therapies Inc. Common Stock shares in Q3 2019, an estimated $2K.
  • Aperio Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Aperio Group's Sio Gene Therapies Inc. Common Stock position peaked at $2K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.